Topics

Pediatric-type diffuse high-grade gliomas | Treatment | Clinical trials | Vaccines

Home > Publications > Topics > Pediatric-type diffuse high-grade gliomas > Treatment > Clinical trials > Vaccines

Thompson EM, Ashley DM, Ayasoufi K, Norberg P, Archer G, Buckley ED, Herndon JE 2nd, Walter A, Archambault B, Flahiff C, Jaggers D, Gorski L, Sanchez LA, Congdon K, Hotchkiss K, Cook SL, Moelker E, Vlahovic G, Reap E, Schroeder K, Randazzo D, Desjardins A, Johnson MO, Peters K, Khasraw M, Friedman H, Mitchell DA, Sampson JH, Landi D.
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.
Nat Cancer. 2025 Jun 12. doi: 10.1038/s43018-025-00998-z. PMID: 40506525. Interventional study˰ ˍ